• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制磷酸酶 SHIP-1 增强了人血嗜碱性粒细胞亚最佳 IgE 介导的激活,但抑制了培养的人肥大细胞的 IgE 介导的激活。

Inhibiting phosphatase SHIP-1 enhances suboptimal IgE-mediated activation of human blood basophils but inhibits IgE-mediated activation of cultured human mast cells.

机构信息

Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Denmark.

Department of Engineering, Aarhus University, Denmark.

出版信息

Immunol Lett. 2019 Jun;210:40-46. doi: 10.1016/j.imlet.2019.04.003. Epub 2019 Apr 17.

DOI:10.1016/j.imlet.2019.04.003
PMID:31004680
Abstract

IgE-mediated activation of basophil granulocytes and mast cells follows a bell-shaped dose-response curve. The decreased activation at supraoptimal allergen stimulation is thought to be associated with SH2-containing inositol-5'-phosphatase 1 (SHIP-1). SHIP-1 phosphorylation is inversely related to IgE-mediated releasability of basophils. This study sought to clarify the regulatory role of SHIP-1 in degranulation of basophil granulocytes and mast cells by selective inhibition of the phosphatase function of SHIP-1with 3-α-aminocholestane (3-α-AC). Six grass pollen allergic patients, six non-responder patients and six cultured human primary mast cell lines were included. The effect of 3-α-AC (1-60 μM, 30 min, 37 °C) was analyzed at individual suboptimal, optimal and supra-optimal allergen concentrations. The activity, upregulation of CD63, measured at different conditions was compared to evaluate the maximal effect of selective SHIP-1 inhibition. Basophils of five non-responder patients were treated with 3-α-AC (10 μM, 30 min, 37 °C). At high concentrations (>60 μM) of 3-α-AC, cells appeared to enter apoptosis. The median reactivity increased from 27.1% to 44.9% CD63 basophils at 10 μM of 3-α-AC and suboptimal allergen stimulation (p = 0.0153). There was no effect on blood basophils of 3-α-AC at optimal or supra-optimal allergen concentrations. In contrast, treatment with more than 6 μM 3-α-AC significantly inhibited mast cell reactivity. 10 μM 3-α-AC reduced median reactivity from 32.85% to 16.5% CD63+ mast cells (p = 0.0465). Treatment with 3-α-AC did not increase response of basophils of non-responder patients. Modulating blood basophils with 3-α-AC enhanced reactivity only at suboptimal allergen concentration, and basophils from non-responders did not regain responsiveness to IgE stimulation. 3-α-AC inhibited the IgE response of mast cells in a dose dependent manner.

摘要

免疫球蛋白 E 介导的嗜碱性粒细胞和肥大细胞的激活遵循钟形剂量反应曲线。在超最佳过敏原刺激下,活性降低被认为与含 SH2 的肌醇 5'-磷酸酶 1(SHIP-1)有关。SHIP-1 的磷酸化与 IgE 介导的嗜碱性粒细胞释放能力呈负相关。本研究旨在通过选择性抑制 SHIP-1 的磷酸酶功能,用 3-α-氨基胆甾烷(3-α-AC)来阐明 SHIP-1 在嗜碱性粒细胞和肥大细胞脱颗粒中的调节作用。纳入了 6 名花粉过敏患者、6 名无反应患者和 6 个人源原代肥大细胞系。在个体亚最佳、最佳和超最佳过敏原浓度下分析 3-α-AC(1-60μM,30min,37°C)的作用。比较不同条件下 CD63 的上调和活性,以评估选择性 SHIP-1 抑制的最大效果。用 3-α-AC(10μM,30min,37°C)处理 5 名无反应患者的嗜碱性粒细胞。在 3-α-AC 的高浓度(>60μM)下,细胞似乎进入了凋亡。在 10μM 3-α-AC 和亚最佳过敏原刺激下,CD63 嗜碱性粒细胞的中位数反应性从 27.1%增加到 44.9%(p=0.0153)。在最佳或超最佳过敏原浓度下,3-α-AC 对血液嗜碱性粒细胞没有影响。相比之下,用 6μM 以上的 3-α-AC 处理显著抑制了肥大细胞的反应性。用 10μM 3-α-AC 可使 CD63+肥大细胞的中位数反应性从 32.85%降低至 16.5%(p=0.0465)。用 3-α-AC 处理不能增加无反应患者嗜碱性粒细胞的反应性。用 3-α-AC 调节血液嗜碱性粒细胞仅在亚最佳过敏原浓度下增强反应性,而无反应者的嗜碱性粒细胞不能重新获得对 IgE 刺激的反应性。3-α-AC 以剂量依赖的方式抑制肥大细胞的 IgE 反应。

相似文献

1
Inhibiting phosphatase SHIP-1 enhances suboptimal IgE-mediated activation of human blood basophils but inhibits IgE-mediated activation of cultured human mast cells.抑制磷酸酶 SHIP-1 增强了人血嗜碱性粒细胞亚最佳 IgE 介导的激活,但抑制了培养的人肥大细胞的 IgE 介导的激活。
Immunol Lett. 2019 Jun;210:40-46. doi: 10.1016/j.imlet.2019.04.003. Epub 2019 Apr 17.
2
SHIP1 and the negative control of mast cell/basophil activation by supra-optimal antigen concentrations.SHIP1与超最佳抗原浓度对肥大细胞/嗜碱性粒细胞激活的负调控
Mol Immunol. 2015 Jan;63(1):32-7. doi: 10.1016/j.molimm.2014.02.017. Epub 2014 Mar 25.
3
Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation.初始FcεRI介导的信号强度在调节嗜碱性粒细胞信号传导和失活中起关键作用。
J Allergy Clin Immunol. 2006 Nov;118(5):1060-7. doi: 10.1016/j.jaci.2006.07.022. Epub 2006 Sep 8.
4
Distinct Contributory Factors Determine Basophil-Allergen Sensitivity in Grass Pollen Rhinitis and in Anaphylactic Wasp Venom Allergy.不同的促成因素决定了草花粉性鼻炎和过敏性黄蜂毒液过敏中嗜碱性粒细胞-过敏原敏感性。
Int Arch Allergy Immunol. 2016;171(2):89-101. doi: 10.1159/000452102. Epub 2016 Dec 2.
5
SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels.SHIP在超最佳IgE或抗原水平下调FcepsilonR1诱导的脱颗粒作用。
J Immunol. 2005 Jan 1;174(1):507-16. doi: 10.4049/jimmunol.174.1.507.
6
Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.嗜碱性粒细胞FcepsilonRI组胺释放与慢性特发性荨麻疹中含Src同源2结构域的肌醇磷酸酶的表达平行。
J Allergy Clin Immunol. 2007 Feb;119(2):441-8. doi: 10.1016/j.jaci.2006.09.035. Epub 2006 Nov 27.
7
Pretreatment with low levels of FcεRI-crosslinking stimulation enhances basophil mediator release.低水平 FcεRI 交联刺激预处理可增强嗜碱性粒细胞介质释放。
Int Arch Allergy Immunol. 2013;161 Suppl 2:23-31. doi: 10.1159/000350339. Epub 2013 May 29.
8
Activation of Human Basophils by A549 Lung Epithelial Cells Reveals a Novel IgE-Dependent Response Independent of Allergen.A549肺上皮细胞对人嗜碱性粒细胞的激活揭示了一种独立于过敏原的新型IgE依赖性反应。
J Immunol. 2017 Aug 1;199(3):855-865. doi: 10.4049/jimmunol.1700055. Epub 2017 Jun 26.
9
A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T-Helper Type 2 and B-Cell Responses in Grass Pollen-induced Allergic Inflammation.人表面活性蛋白D的重组片段可抑制草花粉诱导的过敏性炎症中嗜碱性粒细胞的活化以及2型辅助性T细胞和B细胞反应。
Am J Respir Crit Care Med. 2017 Dec 15;196(12):1526-1534. doi: 10.1164/rccm.201701-0225OC.
10
IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy.IgE 和 IgG 抗体作为食物过敏中肥大细胞和嗜碱性粒细胞功能的调节剂。
Front Immunol. 2020 Dec 11;11:603050. doi: 10.3389/fimmu.2020.603050. eCollection 2020.